Furthermore, mutant p53 shows oncogenic gain-of-function (GOF) activities, such as enhanced tumor progression, metastatic potential, and drug resistance, when overexpressed even in cells deficient wild-type p53 (7)
Furthermore, mutant p53 shows oncogenic gain-of-function (GOF) activities, such as enhanced tumor progression, metastatic potential, and drug resistance, when overexpressed even in cells deficient wild-type p53 (7). malignancy therapy. Distinct approaches have already been taken to develop small-molecule substances that specifically target mutant p53. Such as compounds that restore wild-type conformation and transcriptional activity of…